Your browser doesn't support javascript.
loading
Impact of Dose, Duration, and Immune Status on Efficacy of Ultrashort Telacebec Regimens in Mouse Models of Buruli Ulcer.
Komm, Oliver; Almeida, Deepak V; Converse, Paul J; Omansen, Till F; Nuermberger, Eric L.
Afiliación
  • Komm O; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins Universitygrid.21107.35grid.471401.7, Baltimore, Maryland, USA.
  • Almeida DV; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Converse PJ; First Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Omansen TF; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins Universitygrid.21107.35grid.471401.7, Baltimore, Maryland, USA.
  • Nuermberger EL; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins Universitygrid.21107.35grid.471401.7, Baltimore, Maryland, USA.
Antimicrob Agents Chemother ; 65(11): e0141821, 2021 10 18.
Article en En | MEDLINE | ID: mdl-34460302
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Mycobacterium ulcerans / Úlcera de Buruli Límite: Animals Idioma: En Revista: Antimicrob Agents Chemother Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Mycobacterium ulcerans / Úlcera de Buruli Límite: Animals Idioma: En Revista: Antimicrob Agents Chemother Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos